System and method for screening rna aptamer
AssigneeCRISmers Biotechnologies (Shenzhen) Co., Ltd.
InventorsYu WANG, Ju ZHANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeCRISmers Biotechnologies (Shenzhen) Co., Ltd.
InventorsYu WANG, Ju ZHANG
Estimating the term…
Disclosed is a CRISPR/Cas based system for screening an RNA aptamer against a target protein, comprising: (i) a guide RNA comprising a recognition sequence and a nucleic acid aptamer random library having a predetermined length; (ii) a target sequence complementary to the recognition sequence of the guide RNA; (iii) a selection marker located downstream of the target sequence and comprising a basal promoter and a selection marker gene; (iv) a fusion protein comprising the target protein and a transcriptional activation module, wherein a binding of the target protein to an RNA aptamer of the nucleic acid aptamer random library results in recruitment of the transcriptional activation module to the selection marker; (v) a dCas protein specifically recognizing the target sequence under the guidance of the guide RNA; and (vi) a screening cell. Also disclosed is a method for screening an RNA aptamer against a target protein using the system provided herein and RNA aptamers against S1 protein of SARS-CoV-2 virus and applications thereof.
A system for screening an RNA aptamer against a target protein, comprising:
(canceled)
5-6. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
17-18. (canceled)
20-21. (canceled)
25-26. (canceled)
A method for screening an RNA aptamer against a target protein, comprising:
(canceled)
30-31. (canceled)
34-36. (canceled)
(canceled)
(canceled)
42-55. (canceled)
Dependencies are inferred from the claim text.